JENNIFER WITTMAN: Open Payments
NPI 1013564996 · CORALVILLE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 23 payments from 12 companies in 2025. Trend: 2023 $19,444 · 2024 $253 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $139 |
| Alkermes, Inc. | 1 | $121 |
| PFIZER INC. | 3 | $52 |
| Insulet Corporation | 1 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: LYBALVI, VRAYLAR, NURTEC ODT, QULIPTA, OMNIPOD, CAPLYTA, REXULTI, SPRAVATO.
Industry payments across IA — which companies pay providers there.
